Financial statements Murator Ibs
Cash inflows of MURATOR IBS
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Net cash from operating expenses | -23 569 892,29 | 26 377 497,18 | 445 172,41 | -3 625 806,80 | -9 909 975,96 | 7 611 368,40 |
Net cash flow from investing activities | 22 008 999,51 | -26 319 997,18 | 6 874 650,66 | 3 564 662,40 | -27 288 925,84 | -1 522 200,12 |
Net cash flow from financial activities | 1 383 391,98 | 280 108,01 | -5 871 054,11 | -273 821,24 | 36 756 584,85 | 2 466 876,36 |
Total net cash flow | -177 500,80 | 337 608,01 | 1 448 768,96 | -334 965,64 | -442 316,95 | 8 556 044,64 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.